By Topher Avery
Original Source: drugaddictionnow.com
To mitigate the risk of addiction from prescribed opioid pain medication, the United States Food and Drug Administration (FDA) has called for the development of better technological devices for pain treatment. To this end, the FDA has announced an opioid crisis product challenge.
In a press release posted on the FDA official website on May 30, 2018, the agency announced that it was launching an innovation challenge aimed toward bolstering the development of technological devices which can help treat pain, thereby circumventing the risk of substance abuse which accompanies even properly prescribed…click here to continue reading